Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-10-28 Purchase | 2024-10-30 6:12 pm | Septerna Inc. | SEPN | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 4,170,000 | $18 | $75,060,000 | 1,471,943 (Indirect) | View |
2024-10-28 Purchase | 2024-10-28 4:53 pm | Septerna Inc. | SEPN | Third Rock Ventures V L.P. Third Rock Ventures GP V LP TRV GP V LLC Third Rock Ventures VI L.P. Third Rock Ventures GP VI L.P. TRV GP VI LLC 10% Owner | 650,000 | $18 | $11,700,000 | 9,368,047 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-10-28 Conversion | 2024-10-30 6:12 pm | N/A N/A | Septerna Inc. | SEPN | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 27,157,350 | $0 | 1,471,943 (Indirect) | View |
2024-10-28 Conversion | 2024-10-28 4:53 pm | N/A N/A | Septerna Inc. | SEPN | Third Rock Ventures V L.P. Third Rock Ventures GP V LP TRV GP V LLC Third Rock Ventures VI L.P. Third Rock Ventures GP VI L.P. TRV GP VI LLC 10% Owner | 73,650,746 | $0 | 9,368,047 (Direct) | View |
Ownership | 2024-10-24 9:40 pm | N/A N/A | Septerna Inc. | SEPN | Bhatt Elizabeth Chief Operating Officer | 0 | $0 | 414,871 (Direct) | View |
Ownership | 2024-10-24 9:37 pm | N/A N/A | Septerna Inc. | SEPN | Xiao Ran Interim CFO | 0 | $0 | 84,198 (Direct) | View |
Ownership | 2024-10-24 9:37 pm | N/A 2034-09-25 | Septerna Inc. | SEPN | Kim Jae B. Chief Medical Officer | 0 | $0 | 185,823 (Direct) | View |
Ownership | 2024-10-24 9:34 pm | N/A N/A | Septerna Inc. | SEPN | Klein Uwe SVP, Biological Sciences | 0 | $0 | 180,014 (Indirect) | View |
Ownership | 2024-10-24 9:34 pm | N/A 2034-09-22 | Septerna Inc. | SEPN | Tong Jeffrey K Director | 0 | $0 | 13,356 (Direct) | View |
Ownership | 2024-10-24 9:31 pm | N/A 2033-03-30 | Septerna Inc. | SEPN | Shaikhly Samira Chief People Officer | 0 | $0 | 129,824 (Direct) | View |
Ownership | 2024-10-24 9:30 pm | N/A N/A | Septerna Inc. | SEPN | Third Rock Ventures V L.P. Third Rock Ventures GP V LP TRV GP V LLC Third Rock Ventures VI L.P. Third Rock Ventures GP VI L.P. TRV GP VI LLC 10% Owner | 0 | $0 | 8,718,047 (Direct) | View |
Ownership | 2024-10-24 9:30 pm | N/A N/A | Septerna Inc. | SEPN | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 0 | $0 | 2,839,214 (Indirect) | View |
Ownership | 2024-10-24 9:29 pm | N/A N/A | Septerna Inc. | SEPN | Finer Jeffrey CEO and President | 0 | $0 | 1,857,013 (Direct) | View |
Ownership | 2024-10-24 9:28 pm | N/A N/A | Septerna Inc. | SEPN | Ezekowitz Alan Director | 0 | $0 | 92,328 (Direct) | View |
Ownership | 2024-10-24 9:28 pm | N/A 2034-01-23 | Septerna Inc. | SEPN | Sharp Shalini Director | 0 | $0 | 52,261 (Direct) | View |
Ownership | 2024-10-24 9:25 pm | N/A 2034-09-22 | Septerna Inc. | SEPN | Simson Jake Director | 0 | $0 | 13,356 (Direct) | View |
Ownership | 2024-10-24 9:24 pm | N/A 2033-12-07 | Septerna Inc. | SEPN | Coulie Bernard Director | 0 | $0 | 52,261 (Direct) | View |
Ownership | 2024-10-24 9:23 pm | N/A 2034-09-22 | Septerna Inc. | SEPN | Bassan Abraham Director | 0 | $0 | 13,356 (Direct) | View |
Ownership | 2024-10-24 9:20 pm | N/A N/A | Septerna Inc. | SEPN | Long Daniel D. SVP, Drug Discovery | 0 | $0 | 168,400 (Direct) | View |